MicroStrategy Incorporated

MicroStrategy Incorporated Earnings Recaps

MSTR Information Technology 3 recaps
Next earnings: February 10, 2027 (estimated) · full calendar
Q3 2026 Oct 31, 2026

Strategy shares fell 7.8% after earnings, despite record quarterly income, as the transcript highlights a potential concern for investors: Bitcoin per share was down 3.7% year to date. The company also raised $5.4 billion in capital during the quarter, while its reported earnings were heavily driven by a $20.9 billion fair value gain on Bitcoin.

Key takeaways
  • Q3 operating income was a record $20.9 billion, net income was $19.1 billion, and diluted EPS was $44.75; the company attributed the results to Bitcoin’s price appreciation and a fair value gain on its digital assets.
  • Bitcoin rose from about $58,700 to $83,600 during the quarter. Strategy ended September with more than 847,600 Bitcoin, and reported 848,517 holdings in its opening remarks.
  • Bitcoin per share was down 3.7% year to date, despite growing at an approximately 23% CAGR since the end of 2020.
  • Strategy raised about $5.4 billion in capital in Q3, bringing year-to-date capital raises to $21.2 billion.
  • At quarter-end, cash and short-term investments were just under $5.9 billion; preferred equity was $13.1 billion, and total equity was $68.5 billion, up 51% during the quarter.
Q2 2026 Aug 2, 2026

Hercules Capital shares declined marginally (-0.1%) following Q2 results that reflected stable operating metrics but lacked a clear catalyst to drive the stock higher amid normalization in prepayments and cautious origination guidance.

Key takeaways
  • Q2 originations of $927 million continued a strong start to 2026, contributing to record first-half originations of $2.74 billion, up 35.6% YoY.
  • Early loan repayments surged to $572.1 million, above the high end of guidance, driven largely by M&A and balance sheet cash, a likely factor in a more defensive positioning.
  • Available unfunded commitments modestly increased to $408.2 million, signaling capital available but a cautious approach to deployment and disciplined underwriting remains.
  • Portfolio remains well-diversified with 50/50 split between life sciences and technology, and 87% first lien exposure maintained to mitigate credit risk.
  • Outlook tempered by expected normalization of prepayments to $200–300 million in Q3 and seasonally lower, back-end weighted originations, with management emphasizing discipline amid competitive deal markets.
Q1 2026 May 7, 2026

The stock rose modestly by 1.6%, reflecting a quarter dominated by unrealized Bitcoin losses and operating losses driven by Bitcoin price declines, with no clear upside surprise to significantly uplift investor sentiment.

Key takeaways
  • Reported operating loss of $14.5 billion and net loss of $12.8 billion primarily due to mark-to-market Bitcoin price decline.
  • Bitcoin holdings increased to 818,334 BTC, representing 3.9% of total supply, acquired at an average cost of ~$76,000 per Bitcoin.
  • Bitcoin per share grew 18% year-over-year to 213,371 as of May 2026, highlighting ongoing accumulation efforts.
  • Purchased 89,599 Bitcoin in Q1 at an average price of $80,900, and an additional 56,235 coins in Q2 at around $73,400.
  • Balance sheet remains highly liquid with $2.2 billion in cash and net leverage at a modest 9.3%, supported by $13.5 billion preferred equity and $8.2 billion convertible debt.